Religare Enterprises Limited (NSE:RELIGARE)
India · Delayed Price · Currency is INR 259.65
-9.96 (-3.69%)
Aug 1, 2025, 3:30 PM IST
Religare Enterprises Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Premiums & Annuity Revenue | 63,459 | 53,254 | 39,293 | 25,091 | 17,295 | Upgrade |
Total Interest & Dividend Income | 6,975 | 6,019 | 5,098 | 4,617 | 5,432 | Upgrade |
Gain (Loss) on Sale of Investments | - | 240.03 | 158.05 | 154.41 | -170.65 | Upgrade |
Other Revenue | 3,534 | 3,317 | 2,304 | 3,767 | 2,484 | Upgrade |
| 73,969 | 62,830 | 46,854 | 33,630 | 25,040 | Upgrade | |
Revenue Growth (YoY) | 17.73% | 34.10% | 39.32% | 34.31% | 6.91% | Upgrade |
Policy Acquisition & Underwriting Costs | 14,461 | 11,611 | 5,095 | 1,835 | 888.81 | Upgrade |
Depreciation & Amortization | 620 | 717.04 | 561.46 | 534.02 | 588.41 | Upgrade |
Selling, General & Administrative | - | 2,084 | 4,461 | 3,350 | 2,003 | Upgrade |
Provision for Bad Debts | - | 3,124 | 2,221 | 275.52 | 64.52 | Upgrade |
Other Operating Expenses | 45,647 | 35,840 | 23,906 | 18,865 | 12,547 | Upgrade |
Total Operating Expenses | 71,164 | 59,865 | 42,561 | 36,521 | 22,789 | Upgrade |
Operating Income | 2,804 | 2,965 | 4,292 | -2,891 | 2,251 | Upgrade |
Interest Expense | -371.38 | -911.05 | -6,265 | -7,380 | -7,199 | Upgrade |
Earnings From Equity Investments | - | - | - | -0.97 | -0.84 | Upgrade |
Currency Exchange Gain (Loss) | - | -2.38 | - | -5.03 | -10.09 | Upgrade |
Other Non Operating Income (Expenses) | - | 135.44 | 1,733 | -37.54 | -19.44 | Upgrade |
EBT Excluding Unusual Items | 2,433 | 2,187 | -239.27 | -10,314 | -4,978 | Upgrade |
Gain (Loss) on Sale of Investments | - | -16.09 | -69.34 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 2.6 | 0.84 | 3.27 | 3.62 | Upgrade |
Other Unusual Items | - | 2,303 | 32,894 | - | - | Upgrade |
Pretax Income | 2,433 | 4,477 | 32,586 | -10,311 | -4,975 | Upgrade |
Income Tax Expense | 599.76 | 1,003 | 900.16 | 5,075 | -196.44 | Upgrade |
Earnings From Continuing Ops. | 1,833 | 3,474 | 31,686 | -15,385 | -4,778 | Upgrade |
Minority Interest in Earnings | -581.31 | -1,145 | -869.31 | -53.52 | -306.44 | Upgrade |
Net Income | 1,252 | 2,329 | 30,817 | -15,439 | -5,085 | Upgrade |
Net Income to Common | 1,252 | 2,329 | 30,817 | -15,439 | -5,085 | Upgrade |
Net Income Growth | -46.25% | -92.44% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 330 | 327 | 321 | 301 | 259 | Upgrade |
Shares Outstanding (Diluted) | 331 | 329 | 325 | 301 | 259 | Upgrade |
Shares Change (YoY) | 0.70% | 1.06% | 8.20% | 16.25% | 9.75% | Upgrade |
EPS (Basic) | 3.79 | 7.13 | 96.06 | -51.33 | -19.65 | Upgrade |
EPS (Diluted) | 3.78 | 7.07 | 94.67 | -51.33 | -19.69 | Upgrade |
EPS Growth | -46.54% | -92.53% | - | - | - | Upgrade |
Free Cash Flow | 15,470 | 14,782 | 14,656 | 15,564 | 13,544 | Upgrade |
Free Cash Flow Per Share | 46.71 | 44.95 | 45.03 | 51.74 | 52.34 | Upgrade |
Operating Margin | 3.79% | 4.72% | 9.16% | -8.60% | 8.99% | Upgrade |
Profit Margin | 1.69% | 3.71% | 65.77% | -45.91% | -20.31% | Upgrade |
Free Cash Flow Margin | 20.91% | 23.53% | 31.28% | 46.28% | 54.09% | Upgrade |
EBITDA | 3,404 | 3,143 | 4,472 | -2,767 | 2,368 | Upgrade |
EBITDA Margin | 4.60% | 5.00% | 9.54% | -8.23% | 9.46% | Upgrade |
D&A For EBITDA | 600.06 | 178.15 | 180.29 | 123.77 | 116.58 | Upgrade |
EBIT | 2,804 | 2,965 | 4,292 | -2,891 | 2,251 | Upgrade |
EBIT Margin | 3.79% | 4.72% | 9.16% | -8.60% | 8.99% | Upgrade |
Effective Tax Rate | 24.65% | 22.40% | 2.76% | - | - | Upgrade |
Revenue as Reported | 73,969 | 62,993 | 48,632 | 33,724 | 25,305 | Upgrade |
Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.